- The document discusses International Nonproprietary Names (INN), which are unique generic names designated by the WHO to identify pharmaceutical substances and ensure clear communication among health professionals worldwide.
- The INN system began in 1950 and now includes over 7,000 names. Names are selected by experts to be distinctive, not too long, and avoid confusion. Rights of trademark owners are protected during the selection process.
- INNs identify the active substance, while trade names identify finished products. INNs are intended for public use without restriction and should not be trademarked to ensure universal application.